NCT04837040 - A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 12, 2021

Primary Completion Date

July 10, 2023

Study Completion Date

June 30, 2027

Conditions

Acromegaly

Interventions

DRUG

Paltusotine

Paltusotine, tablets, once daily by mouth

DRUG

Placebo

Placebo, tablets, once daily by mouth

Trial Locations (39)

1083

Crinetics Study Site, Budapest

1431

Crinetics Study Site, Sofia

7624

Crinetics Study Site, Pécs

9000

Crinetics Study Site, Ghent

11000

Crinetics Study Site, Belgrade

15023

Crinetics Study Site, San Isidro

15212

Crinetics Study Site, Pittsburgh

19104

Crinetics Study Site, Philadelphia

21205

Crinetics Study Site, Baltimore

33604

Crinetics Study Site, Pessac

37203

Crinetics Study Site, Nashville

69677

Crinetics Study Site, Bron

90048

Crinetics Study Site, Los Angeles

90502

Crinetics Study Site, Torrance

117186

Crinetics Study Site, Moscow

119435

Crinetics Study Site, Moscow

125008

Crinetics Study Site, Moscow

420097

Crinetics Study Site, Kazan'

443041

Crinetics Study Site, Samara

630005

Crinetics Study Site, Novosibirsk

630087

Crinetics Study Site, Novosibirsk

650066

Crinetics Study Site, Kemerovo

4941480

Crinetics Study Site, Petah Tikva

8410101

Crinetics Study Site, Beersheba

02114

Crinetics Study Site, Boston

C1012AAR

Crinetics Study Site, CABA

C1405BCH

Crinetics Study Site, Ciudad Autonoma de Buenos Aire

X5000

Crinetics Study Site, Córdoba

60430-275

Crinetics Study Site, Fortaleza

80030-110

Crinetics Study Site, Curitiba

90410-000

Crinetics Study Site, Porto Alegre

20231-092

Crinetics Study Site, Rio de Janeiro

21941-913

Crinetics Study Site, Rio de Janeiro

00168

Crinetics Study Site, Roma

85-605

Crinetics Study Site, Bydgoszcz

60-355

Crinetics Study Site, Poznan

S102JF

Crinetics Study Site, Sheffield

CV2 2DX

Crinetics Study Site, Coventry

W12 0HS

Crinetics Study Site, London